IMPROVEMENTS IN SCALP OUTCOMES WITH ROFLUMILAST FOAM 0.3% FOR PSORIASIS OF THE SCALP AND BODY FROM THE PHASE 3 ARRECTOR TRIAL

Document Type

Conference Proceeding

Publication Date

12-1-2025

Publication Title

Value Health

Volume

28

Issue

12

Share

COinS